Malaysia Data Engine
Server Details
Read-only NPRA pharmaceutical records and pipeline health for Malaysia (5 tools).
- Status
- Healthy
- Last Tested
- Transport
- Streamable HTTP
- URL
Available Tools
6 toolsfind_by_manufacturerFind By ManufacturerARead-onlyIdempotentInspect
Find products and related NPRA records for a manufacturer-name substring.
| Name | Required | Description | Default |
|---|---|---|---|
| name | Yes | Manufacturer-name substring to search for (case-insensitive). |
Output Schema
| Name | Required | Description |
|---|---|---|
No output parameters | ||
TDQS
Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?
Annotations already declare readOnly, openWorld, idempotent, and non-destructive behavior, so the description carries less burden here. It adds the substring-matching scope and the connection to NPRA records, but does not disclose additional behavior such as result limits, ordering, or relationship semantics.
Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.
Is the description appropriately sized, front-loaded, and free of redundancy?
The description is a single, well-structured sentence that front-loads the action and resource, then specifies the search criterion. It contains no filler or redundancy.
Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.
Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?
The tool is simple, has one well-documented parameter, a rich annotation set, and an output schema, so the description is largely sufficient. It could be slightly stronger by relating itself to sibling search tools, but nothing critical is missing for correct invocation.
Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.
Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?
The schema already documents the single parameter fully, including its case-insensitive substring semantics and length constraints. The description adds little beyond restating that the search is by manufacturer-name substring, so the high schema coverage sets the baseline at 3.
Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.
Does the description clearly state what the tool does and how it differs from similar tools?
The description clearly states the tool's action: finding products and related NPRA records based on a manufacturer-name substring. It identifies the resource and the matching criterion, though it does not explicitly differentiate itself from sibling search tools.
Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.
Does the description explain when to use this tool, when not to, or what alternatives exist?
The description makes it clear when this tool is appropriate: when searching by a manufacturer-name substring. It provides useful context for selection but does not explicitly state when not to use it or name alternative tools.
Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.
find_recent_changesFind Recent ChangesARead-onlyIdempotentInspect
Return deduplicated changes from the dated pipeline delta artefacts.
| Name | Required | Description | Default |
|---|---|---|---|
| category | No | Filter changes to one category; all categories by default. | |
| window_days | No | Number of days back to include registry changes. Default 7. |
Output Schema
| Name | Required | Description |
|---|---|---|
No output parameters | ||
TDQS
Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?
Annotations already convey read-only, open-world, idempotent, and non-destructive behavior. The description adds value by disclosing that results are deduplicated and sourced from dated pipeline delta artefacts, which are behavioral details beyond the annotations.
Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.
Is the description appropriately sized, front-loaded, and free of redundancy?
The description is a single compact sentence with no filler. It is slightly jargon-heavy ('delta artefacts'), but every part earns its place and the core behavior is front-loaded.
Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.
Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?
With a high-coverage schema, an output schema, and strong annotations, the description is largely sufficient. The main gap is not clarifying how 'deduplicated' applies or when the 'pipeline delta artefacts' are considered 'recent', but overall the definition enables correct invocation.
Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.
Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?
Schema description coverage is 100%, so the parameters are already well documented in the schema. The description adds no additional meaning for 'category' or 'window_days', but it does not need to since the schema already explains them.
Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.
Does the description clearly state what the tool does and how it differs from similar tools?
The description states a specific verb ('Return'), a specific resource ('changes from the dated pipeline delta artefacts'), and a distinguishing behavior ('deduplicated'). This makes the tool's core purpose understandable, though it does not explicitly contrast it with sibling tools.
Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.
Does the description explain when to use this tool, when not to, or what alternatives exist?
No guidance is given about when to use this tool versus sibling tools like find_by_manufacturer or search_pharma. The description implies a use case around recent changes, but there are no explicit conditions, exclusions, or alternative routes.
Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.
get_npra_recordGet Npra RecordARead-onlyIdempotentInspect
Return one exact NPRA record, searching all categories by default.
| Name | Required | Description | Default |
|---|---|---|---|
| reg_no | Yes | Exact NPRA registration number to look up (e.g. MAL16100027TCR). | |
| category | No | Filter the lookup to one NPRA category; defaults to searching all categories. |
Output Schema
| Name | Required | Description |
|---|---|---|
No output parameters | ||
TDQS
Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?
Annotations already establish read-only, idempotent, non-destructive behavior. The description adds meaningful behavioral context beyond annotations by clarifying that exactly one record is returned and that category filtering defaults to all categories. No contradiction with annotations.
Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.
Is the description appropriately sized, front-loaded, and free of redundancy?
A single, efficient sentence with no filler. The core lookup behavior and default category behavior are front-loaded, making it easy for an agent to parse quickly.
Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.
Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?
For a simple read-only exact lookup with two well-documented parameters, an output schema, and strong annotations, the description is nearly complete. It could be slightly stronger by pointing to sibling search tools for non-exact queries, but that is a minor gap.
Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.
Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?
Schema description coverage is 100%, with reg_no including an example and category fully documenting defaults and allowed values. The description reinforces the 'all categories by default' behavior but does not add much beyond the schema.
Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.
Does the description clearly state what the tool does and how it differs from similar tools?
The description states a specific verb ('Return') and resource ('one exact NPRA record'), and 'searching all categories by default' adds useful scope. It does not explicitly name sibling tools, but the word 'exact' distinguishes this lookup from search/find tools.
Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.
Does the description explain when to use this tool, when not to, or what alternatives exist?
The description implies this tool is for exact registration-number lookups, especially when category is unknown. However, it does not explicitly tell the agent when to prefer search_pharma or find_by_manufacturer, nor does it state exclusions such as 'do not use for partial or fuzzy matches.'
Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.
get_pharma_healthGet Pharma HealthARead-onlyIdempotentInspect
Return the pipeline-produced pharma health document verbatim.
| Name | Required | Description | Default |
|---|---|---|---|
No parameters | |||
Output Schema
| Name | Required | Description |
|---|---|---|
No output parameters | ||
TDQS
Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?
Annotations already provide a strong safety profile (read-only, idempotent, non-destructive), and the description adds useful context: the document is pipeline-produced and returned verbatim. However, it does not disclose much beyond that, such as freshness, persistence, or access considerations.
Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.
Is the description appropriately sized, front-loaded, and free of redundancy?
The description is a single focused sentence with no wasted words. It front-loads the key information: what is returned and how it is returned, which is all this parameterless tool needs.
Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.
Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?
With no parameters, an output schema available, and rich annotations covering safety, the description sufficiently defines the tool's role. An agent can invoke it correctly without needing additional behavioral detail.
Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.
Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?
The tool has zero parameters and the schema coverage is 100%, so there are no parameter semantics for the description to clarify. It correctly avoids inventing unnecessary parameter details.
Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.
Does the description clearly state what the tool does and how it differs from similar tools?
The description clearly states a specific action ('Return') and resource ('pipeline-produced pharma health document') and emphasizes 'verbatim', which distinguishes it from sibling tools that search or verify records. This leaves little ambiguity about what the tool does.
Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.
Does the description explain when to use this tool, when not to, or what alternatives exist?
The description implies the tool should be used when the exact pharma health document is needed, but it does not explicitly say when to prefer it over siblings like search_pharma or verify_pharma_artifact. Usage context is present by implication, not explicit guidance.
Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.
search_pharmaSearch PharmaBRead-onlyIdempotentInspect
Search one NPRA category by its public searchable fields.
| Name | Required | Description | Default |
|---|---|---|---|
| q | Yes | Case-insensitive substring to search for. | |
| limit | No | Maximum number of matching products to return. Default 20. | |
| category | No | NPRA category to search. Defaults to products. | products |
Output Schema
| Name | Required | Description |
|---|---|---|
No output parameters | ||
TDQS
Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?
No annotations are provided, so the description carries the full burden of behavioral disclosure. It mentions 'public searchable fields' but does not disclose behavior such as result format, pagination, matching semantics, or what happens when no matches are found. This is a minimal disclosure for a search tool.
Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.
Is the description appropriately sized, front-loaded, and free of redundancy?
The description is a single, front-loaded sentence with no filler or repetition. It conveys the core action and scope efficiently, making it easy for an agent to parse quickly.
Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.
Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?
Given that the tool is a simple search endpoint with three well-documented parameters and no output schema, the description plus schema is minimally adequate for invocation. However, the absence of usage context, sibling differentiation, and any note about return structure leaves some gaps in the overall context an agent might need.
Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.
Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?
The input schema thoroughly documents all three parameters with descriptions, defaults, and constraints. The description adds little beyond the schema—it only implies that searching happens across 'public searchable fields' and within one category. With high schema coverage, the baseline of 3 is appropriate.
Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.
Does the description clearly state what the tool does and how it differs from similar tools?
The description clearly states the action ('Search') and the resource ('one NPRA category'), and specifies it operates on 'public searchable fields.' It is specific enough to distinguish from a generic search tool, though it does not name sibling tools for explicit differentiation.
Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.
Does the description explain when to use this tool, when not to, or what alternatives exist?
The description gives no guidance about when to use this tool versus alternatives, no context about preferred scenarios, and no exclusions. Usage must be inferred from the generic phrasing 'Search one NPRA category,' which is not sufficient for scenario-based selection.
Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.
verify_pharma_artifactVerify Pharma ArtifactARead-onlyIdempotentInspect
Verify the current canonical pharma graph's local Sigstore DSSE bundle.
| Name | Required | Description | Default |
|---|---|---|---|
| include_proof_steps | No | Include capped output from the offline cosign verification command. Default false. |
Output Schema
| Name | Required | Description |
|---|---|---|
No output parameters | ||
TDQS
Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?
Annotations already declare the tool read-only, idempotent, and non-destructive, so the bar is lower. The description adds useful scoping context ('current canonical', 'local') and specifies the exact artifact type without contradicting the annotations.
Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.
Is the description appropriately sized, front-loaded, and free of redundancy?
The description is a single compact sentence with zero filler. The verb and object are immediately clear and front-loaded.
Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.
Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?
For a simple, read-only verification tool with one optional parameter, full schema coverage, an output schema, and safety annotations, the description is sufficient. It identifies the target artifact, and the annotations and output schema cover behavior and return shape.
Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.
Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?
Schema description coverage is 100% for the single optional boolean include_proof_steps, so the schema fully documents parameters. The description adds no parameter-level detail, but the baseline of 3 is appropriate because the schema carries the burden.
Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.
Does the description clearly state what the tool does and how it differs from similar tools?
The description names a specific operation ('Verify') and a precise object ('the current canonical pharma graph's local Sigstore DSSE bundle'). It is clearly distinct from the sibling tools, which are lookup/search-oriented.
Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.
Does the description explain when to use this tool, when not to, or what alternatives exist?
There is no explicit guidance on when to use this tool versus the sibling find/search/get tools. The verification intent is implied but no conditions, exclusions, or alternatives are stated.
Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.
Tool Schema Changelog
Recent tool additions, removals, and schema changes observed during successful MCP inspections. Dates show when Glama detected each change.
6 tool updates
- First observed
find_by_manufacturer - First observed
find_recent_changes - First observed
get_npra_record - First observed
get_pharma_health - First observed
search_pharma - First observed
verify_pharma_artifact
Frequently Asked Questions
Claiming proves that you control a remote MCP connector. It does not move, proxy, or interrupt the server.
Open the connector listing, choose Claim ownership, and sign in to Glama.
Complete one verification method:
GitHub identity — fastest for official registry listings. For a namespace such as
io.github.alice/server, link the matching GitHub user, then choose Claim with GitHub. An organization namespace such asio.github.acme/serveralso needs that organization to have installed the Glama AI GitHub App and approved its permissions, because GitHub discloses organization membership only to apps it has installed. Use HTTP or DNS when it has not.HTTP challenge — works when you can deploy a public file. Generate a token, publish the exact JSON Glama shows at
/.well-known/glama.jsonon the same origin as the connector, then choose Check HTTP challenge.DNS challenge — works when you control DNS but cannot change the server. Generate a token, create the exact TXT record Glama shows, wait for it to propagate, then choose Check DNS challenge.
After verification, Glama sends a confirmation email and gives you access to listing details, thumbnails, health checks, and analytics. Keep the HTTP file or DNS record in place: Glama periodically checks it and ownership remains verified while the token is discoverable.
The HTTP ownership file has this structure:
{
"$schema": "https://glama.ai/mcp/schemas/connector.json",
"claim": "glama_claim_..."
}Claim tokens are opaque, stable, and bound to the signed-in Glama account. They contain no email address or other personal information. If Glama can no longer discover a verified HTTP or DNS token, it starts a seven-day grace period before removing claim-based access. Restore the same token during that period to keep ownership verified. Never publish an email address, Glama session token, GitHub token, or connector credential as ownership proof.
If verification fails, confirm that you copied the current token exactly. The HTTP file must be public, return valid JSON with a successful HTTP response, and stay on the connector's origin. DNS changes may need more time to propagate. A claim cannot transfer to a different origin or hostname: if the connector target changes, Glama starts the grace period and the new target must be claimed separately after the previous claim is released.
For a connector linked to the official MCP Registry, registry updates continue to replace its name, description, and URL by default. After claiming, open Manage connector and enable Use Glama listing details as the source of truth if edits made on Glama should be preserved. Categories and thumbnails are always managed on Glama; registry linkage and technical connection settings continue to sync.
Control your server's listing on Glama, including description and metadata
Access analytics and receive server usage reports
Get monitoring and health status updates for your server
Feature your server to boost visibility and reach more users
To improve your MCP server's ranking:
Claim ownership of the server listing
Complete the server profile with an accurate description and thumbnail
Provide a test profile so Glama can connect to and evaluate the server
Keep tool definitions clear and complete to earn a high Tool Definition Quality Score (TDQS)
Route real usage through the Glama Gateway; more recorded successful server uses also improve the ranking
For users:
Full audit trail – every tool call is logged with inputs and outputs for compliance and debugging
Granular tool control – enable or disable individual tools per connector to limit what your AI agents can do
Centralized credential management – store and rotate API keys and OAuth tokens in one place
Change alerts – get notified when a connector changes its schema, adds or removes tools, or updates tool definitions, so nothing breaks silently
For server owners:
Proven adoption – public usage metrics on your listing show real-world traction and build trust with prospective users
Tool-level analytics – see which tools are being used most, helping you prioritize development and documentation
Direct user feedback – users can report issues and suggest improvements through the listing, giving you a channel you would not have otherwise
The connector status is unhealthy when Glama is unable to successfully connect to the server. This can happen for several reasons:
The server is experiencing an outage
The URL of the server is wrong
Credentials required to access the server are missing or invalid
If you are the owner of this MCP connector and would like to make modifications to the listing, including providing test credentials for accessing the server, please contact support@glama.ai.
Discussions
No comments yet. Be the first to start the discussion!
Related MCP Connectors
Pharma Intel MCP — Compound tools that chain ClinicalTrials.gov,
Read-only discovery for 389 Malaysian public datasets with freshness, licence, and provenance.
NIH clinical trials and FDA adverse event reports. 4 MCP tools for health research.
Orange Book competitive intelligence from FDA's monthly official data ZIP.
Related MCP Servers
- FlicenseNot gradedqualityBmaintenanceEnables local read-only retrieval and search across 27 global medical device regulatory knowledge hubs (NMPA/FDA/MDR/PMDA etc.) using four MCP tools, with zero credentials and no external network calls.-
- AlicenseAqualityAmaintenanceEnables medication reference workflows including drug search, dosing calculations, Taiwan regulatory lookups, hospital prescription helpers, and educational PK/DDI simulation.333Apache 2.0
- AlicenseNot gradedqualityBmaintenancePharmaceutical R\&D Pipeline Intelligence for AI Agents — Clinical trials, FDA approvals, drug information & publications in one MCP server.5MIT
- AlicenseNot gradedqualityDmaintenanceEnables drug safety, interactions, adverse events, and regulatory data queries using free sources like DrugBank, WHO, FDA FAERS, and more. Provides tools for checking drugs, interactions, adverse events, and searching across pharmaceutical databases.MIT
Glama MCP Gateway
Add one secure layer between your agents and this server.
TDQS
Tools are largely distinct, with search_pharma focused on category-specific field search and find_by_manufacturer on manufacturer substring lookup, which could cause occasional confusion. get_npra_record, get_pharma_health, find_recent_changes, and verify_pharma_artifact each have clear, separate purposes.
All tool names use lowercase snake_case with a verb-led pattern, mostly following verb_noun conventions. The main deviation is find_by_manufacturer, which uses a prepositional phrase rather than a direct object, but overall naming is predictable and readable.
Six tools is a well-scoped set for a data retrieval and verification server, covering search, exact lookup, delta tracking, document retrieval, and artifact verification without redundancy or bloat.
The server provides strong coverage for discovery, retrieval, change tracking, and verification of pharma data, fitting its evident read-only role. Minor gaps include no explicit way to list all categories or combine filters across categories beyond the exact record lookup, but these are workarounds.